Exane Derivatives’s Celanese CE Stock Holding History

Exane Derivatives’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$134K	Buy	1,137 +1,132	+22,640%	+$162K	0.08%	235
2022 Q1	$714	Hold	5	–	–	﹤0.01%	836
2021 Q4	$840	Sell	5 -4	-44%	-$651	﹤0.01%	724
2021 Q3	$1.36K	Sell	9 -587	-98%	-$90.4K	﹤0.01%	831
2021 Q2	$91.9K	Buy	596 +42	+8%	+$6.67K	0.02%	550
2021 Q1	$83K	Buy	554 +536	+2,978%	+$73.6K	0.02%	447
2020 Q4	$2.34K	Sell	18 -9,972	-100%	-$1.24M	﹤0.01%	614
2020 Q3	$1.07M	Buy	9,990 +9,988	+499,400%	+$997K	0.31%	74
2020 Q2	$173	Hold	2	–	–	﹤0.01%	658
2020 Q1	$147	Hold	2	–	–	﹤0.01%	668
2019 Q4	$236	Hold	2	–	–	﹤0.01%	646
2019 Q3	$245	Sell	2 -32,733	-100%	-$3.69M	﹤0.01%	620
2019 Q2	$3.53M	Buy	32,735 +32,704	+105,497%	+$3.39M	0.62%	47
2019 Q1	$3.06K	Sell	31 -38,107	-100%	-$3.75M	﹤0.01%	425
2018 Q4	$3.43M	Buy	38,138 +782	+2%	+$76.7K	0.62%	40
2018 Q3	$4.26M	Buy	37,356 +17,531	+88%	+$2.01M	0.8%	26
2018 Q2	$2.2M	Buy	+19,825	New	+$2.19M	0.37%	65
2017 Q3	–	Sell	-3	Closed	-$285	–	584
2017 Q2	$285	Sell	3 -30,810	-100%	-$2.75M	﹤0.01%	521
2017 Q1	$2.77M	Buy	30,813 +30,812	+3,081,200%	+$2.69M	0.63%	51
2016 Q4	$79	Hold	1	–	–	﹤0.01%	555
2016 Q3	$67	Buy	+1	New	+$65	﹤0.01%	552

Other funds holding CE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Exane Derivatives's CE Position: Q2 2022 in Review

Exane Derivatives increased its Celanese (CE) stake by 22,640% in Q2 2022, buying an estimated $162K and bringing the position to 1,137 shares worth $134K. The position accounts for 0.08% of the portfolio, ranked #235.

Exane Derivatives first reported a position in CE in Q3 2016 and has held it in 21 quarters since. The position peaked at $4.26M in Q3 2018. 669 funds tracked by Wall St. Rank hold CE as of Q2 2022.

Exane Derivatives held 1,137 shares of Celanese worth $134K as of Q2 2022.
Exane Derivatives bought 1,132 Celanese shares in Q2 2022, an estimated $162K.
Celanese made up 0.08% of Exane Derivatives's portfolio in Q2 2022, its #235 holding.
Exane Derivatives first reported a position in Celanese in Q3 2016 and has held it in 21 quarters since.
Exane Derivatives's Celanese position peaked at $4.26M in Q3 2018.
669 funds tracked by Wall St. Rank held Celanese as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.